SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17076004
Source:
http://linkedlifedata.com/resource/pubmed/id/17076004
Search
Subject
(
40
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0024348
,
umls-concept:C0027651
,
umls-concept:C0035820
,
umls-concept:C0087111
,
umls-concept:C0449438
,
umls-concept:C0521116
,
umls-concept:C0937932
,
umls-concept:C1174785
pubmed:dateCreated
2006-10-31
pubmed:language
fre
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9421356
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Allopurinol
,
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Urate Oxidase
,
http://linkedlifedata.com/resource/pubmed/chemical/rasburicase
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0929-693X
pubmed:author
pubmed-author:UrbietaMM
pubmed:issnType
Print
pubmed:volume
12 Spec No 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8-12
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17076004-Allopurinol
,
pubmed-meshheading:17076004-Antimetabolites
,
pubmed-meshheading:17076004-Hematologic Neoplasms
,
pubmed-meshheading:17076004-Humans
,
pubmed-meshheading:17076004-Recombinant Proteins
,
pubmed-meshheading:17076004-Renal Insufficiency
,
pubmed-meshheading:17076004-Tumor Lysis Syndrome
,
pubmed-meshheading:17076004-Urate Oxidase
pubmed:year
2005
pubmed:articleTitle
[The current status of the treatment of tumor lysis syndrome--the role of rasburicase (Fasturtec)].
pubmed:affiliation
Laboratoires Sanofi-Aventis, Paris, France. marisol.urbieta@sanofi-aventis.com
pubmed:publicationType
Journal Article